Global X China Biotech UCITS ETF USD Accumulating (USD) | CBIORegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | -16.8 | |
+/-Cat | - | - | - | - | -13.1 | |
+/-B’mrk | - | - | - | - | -23.3 | |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: Morningstar Gbl Biotechnolo... |
Key Stats | ||
Closing Price 01/05/2024 | USD 22.07 | |
Day Change | 0.36% | |
Morningstar Category™ | Sector Equity Biotechnology | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE0004LIBFM2 | |
Fund Size (Mil) 01/05/2024 | USD 1.11 | |
Share Class Size (Mil) 01/05/2024 | USD 1.11 | |
Ongoing Charge 07/02/2023 | 0.68% |
Investment Objective: Global X China Biotech UCITS ETF USD Accumulating (USD) | CBIO |
The investment objective of the Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Biotech v2 USD Index NTR (the “Index”). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 18/01/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Solactive China Biotech v2 NR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Global X China Biotech UCITS ETF USD Accumulating (USD) | CBIO | - |
|
|
Top 5 Holdings | Sector | % |
No Data Available | ||
Increase Decrease New since last portfolio | ||
Global X China Biotech UCITS ETF USD Accumulating (USD) | CBIO |